Post Categories
Consensus Drives Collaboration: In-Depth Cell Analysis Can Accelerate Understanding of the Brain
December 13, 2021
A large team of researchers has made great strides in developing a census and atlas of the cell types found in the mammalian primary…
Chimpanzee DNA Sheds Light on Human Brain Evolution
December 8, 2021
In evolutionary terms, chimpanzees are humans’ closest living relatives. But how close are we, really? Science Daily reports that researchers at Lund University in…
Using Brain Stimulation to “Switch Tracks” in Mental Health Patients’ Train of Thought
December 6, 2021
A proof-of-concept study of brain stimulation among patients with epilepsy may have revealed a revolutionary way to treat people with severe depression, anxiety, addiction…
How Congress Could Regulate Medicare Drug Prices
December 1, 2021
Prescription drug costs continue to be a concern for many Americans. But now, as Congress works to finalize President Biden’s Build Back Better social…
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
November 15, 2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. The processes for manufacturing therapeutic proteins are not very efficient…
Can Gene Therapy Cure Sickle Cell Disease?
November 8, 2021
Despite being one of the world’s most common inherited blood disorders, sickle cell disease has few treatment options, even with the approval of three…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
Gene Therapy for Blood Cancer
November 15, 2023
Blood cancers like leukemia and lymphoma are caused by mutations in the DNA of blood cells. These mutations cause normal blood cells to change into…
PF4 Offers Hope for Rejuvenating Aging Brains and Combatting Cognitive Decline
November 13, 2023
Three separate research studies point to a small protein, platelet-derived chemokine platelet factor 4 (PF4), as a possible tool for combating cognitive decline in…
Gene Therapy for Ocular Disease
November 8, 2023
Gene therapy for ocular disease is a rapidly evolving field with promise as a treatment option for various genetic and acquired eye diseases. It…
The Buzz on Genetically Modified Mosquitoes vs Malaria
November 6, 2023
Malaria has been a devastating disease throughout history, claiming between 150 to 300 million lives in the 20th century alone. Despite significant progress in…
Messenger RNA Delivery by Lipid Nanoparticles (LNPs)
November 1, 2023
What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA)…
mRNA Delivery by Viral Vectors
October 25, 2023
What is it? mRNA delivery by viral vectors is a promising approach in the field of gene therapy and vaccine development. Viral vectors are…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
